Stefan Michiels

37PUBLICATIONS
257CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Feb 05, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group.

Ylva A Weeda, Roberto Salgado, Filip van Herpe

|Sep 12, 2025
Acceptance of external control arms by HTA agencies: a review of oncology submissions in France, England, Germany and Norway from 2021 to 2023.

Matthias Monnereau, Jean-Pierre Delord, Stefan Michiels

|Sep 10, 2025
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis.

Abderaouf Hamza, Pierre Gestraud, Maryam Karimi

|Sep 04, 2025
Patritumab deruxtecan in HR+HER2- advanced breast cancer: a phase 2 trial.

Barbara Pistilli, Fernanda Mosele, Noemie Corcos

|Aug 30, 2025
Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians.

Elie Rassy, Suzette Delaloge, Yannis Slaouti

|Oct 21, 2024
Sustained lymphocyte decreases after treatment for early breast cancer.

Julia Dixon-Douglas, Balaji Virassamy, Kylie Clarke

Pageof 7

Frequent Collaborators

11 joint publications

Fabrice Andre

6 joint publications

Barbara Pistilli

6 joint publications

Luc Friboulet

6 joint publications

Ines Vaz-Luis